The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genotyping Assay-Global Market Insights and Sales Trends 2025
Synopsis
Genotyping assays aim to discriminate between sequences, rather than measure the level of a particular DNA sequence.
The global Genotyping Assay market size is expected to reach US$ 76560 million by 2029, growing at a CAGR of 19.3% from 2023 to 2029. The market is mainly driven by the significant applications of Genotyping Assay in various end use industries. The expanding demands from the Pharmacogenomics, Diagnostic Research, Animal Genetics and Agricultural Biotechnology, are propelling Genotyping Assay market. PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sequencing segment is estimated at % CAGR for the next seven-year period.
North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genotyping Assay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genotyping Assay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genotyping Assay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genotyping Assay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genotyping Assay covered in this report include Illumina, Thermo Fisher Scientific, Roche, Qiagen N.V., Agilent, Fluidigm, Genewiz, Integrated Dna Technologies and Perkinelmer, etc.
The global Genotyping Assay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
Global Genotyping Assay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genotyping Assay market, Segment by Type:
PCR
Sequencing
Microarray
Others
Global Genotyping Assay market, by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genotyping Assay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Genotyping assays aim to discriminate between sequences, rather than measure the level of a particular DNA sequence.
The global Genotyping Assay market size is expected to reach US$ 76560 million by 2029, growing at a CAGR of 19.3% from 2023 to 2029. The market is mainly driven by the significant applications of Genotyping Assay in various end use industries. The expanding demands from the Pharmacogenomics, Diagnostic Research, Animal Genetics and Agricultural Biotechnology, are propelling Genotyping Assay market. PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sequencing segment is estimated at % CAGR for the next seven-year period.
North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genotyping Assay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genotyping Assay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genotyping Assay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genotyping Assay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genotyping Assay covered in this report include Illumina, Thermo Fisher Scientific, Roche, Qiagen N.V., Agilent, Fluidigm, Genewiz, Integrated Dna Technologies and Perkinelmer, etc.
The global Genotyping Assay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
Global Genotyping Assay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genotyping Assay market, Segment by Type:
PCR
Sequencing
Microarray
Others
Global Genotyping Assay market, by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genotyping Assay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genotyping Assay
1.1 Genotyping Assay Market Overview
1.1.1 Genotyping Assay Product Scope
1.1.2 Genotyping Assay Market Status and Outlook
1.2 Global Genotyping Assay Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genotyping Assay Market Size by Region (2018-2029)
1.4 Global Genotyping Assay Historic Market Size by Region (2018-2023)
1.5 Global Genotyping Assay Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genotyping Assay Market Size (2018-2029)
1.6.1 North America Genotyping Assay Market Size (2018-2029)
1.6.2 Europe Genotyping Assay Market Size (2018-2029)
1.6.3 Asia-Pacific Genotyping Assay Market Size (2018-2029)
1.6.4 Latin America Genotyping Assay Market Size (2018-2029)
1.6.5 Middle East & Africa Genotyping Assay Market Size (2018-2029)
2 Genotyping Assay Market by Type
2.1 Introduction
2.1.1 PCR
2.1.2 Sequencing
2.1.3 Microarray
2.1.4 Others
2.2 Global Genotyping Assay Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genotyping Assay Historic Market Size by Type (2018-2023)
2.2.2 Global Genotyping Assay Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genotyping Assay Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genotyping Assay Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genotyping Assay Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genotyping Assay Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genotyping Assay Revenue Breakdown by Type (2018-2029)
3 Genotyping Assay Market Overview by Application
3.1 Introduction
3.1.1 Pharmacogenomics
3.1.2 Diagnostic Research
3.1.3 Animal Genetics
3.1.4 Agricultural Biotechnology
3.1.5 Others
3.2 Global Genotyping Assay Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genotyping Assay Historic Market Size by Application (2018-2023)
3.2.2 Global Genotyping Assay Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genotyping Assay Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genotyping Assay Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genotyping Assay Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genotyping Assay Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genotyping Assay Revenue Breakdown by Application (2018-2029)
4 Genotyping Assay Competition Analysis by Players
4.1 Global Genotyping Assay Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genotyping Assay as of 2022)
4.3 Date of Key Players Enter into Genotyping Assay Market
4.4 Global Top Players Genotyping Assay Headquarters and Area Served
4.5 Key Players Genotyping Assay Product Solution and Service
4.6 Competitive Status
4.6.1 Genotyping Assay Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina Genotyping Assay Products, Services and Solutions
5.1.4 Illumina Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Genotyping Assay Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Genotyping Assay Products, Services and Solutions
5.3.4 Roche Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.3.5 Qiagen N.V. Recent Developments
5.4 Qiagen N.V.
5.4.1 Qiagen N.V. Profile
5.4.2 Qiagen N.V. Main Business
5.4.3 Qiagen N.V. Genotyping Assay Products, Services and Solutions
5.4.4 Qiagen N.V. Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.4.5 Qiagen N.V. Recent Developments
5.5 Agilent
5.5.1 Agilent Profile
5.5.2 Agilent Main Business
5.5.3 Agilent Genotyping Assay Products, Services and Solutions
5.5.4 Agilent Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.5.5 Agilent Recent Developments
5.6 Fluidigm
5.6.1 Fluidigm Profile
5.6.2 Fluidigm Main Business
5.6.3 Fluidigm Genotyping Assay Products, Services and Solutions
5.6.4 Fluidigm Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.6.5 Fluidigm Recent Developments
5.7 Genewiz
5.7.1 Genewiz Profile
5.7.2 Genewiz Main Business
5.7.3 Genewiz Genotyping Assay Products, Services and Solutions
5.7.4 Genewiz Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.7.5 Genewiz Recent Developments
5.8 Integrated Dna Technologies
5.8.1 Integrated Dna Technologies Profile
5.8.2 Integrated Dna Technologies Main Business
5.8.3 Integrated Dna Technologies Genotyping Assay Products, Services and Solutions
5.8.4 Integrated Dna Technologies Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.8.5 Integrated Dna Technologies Recent Developments
5.9 Perkinelmer
5.9.1 Perkinelmer Profile
5.9.2 Perkinelmer Main Business
5.9.3 Perkinelmer Genotyping Assay Products, Services and Solutions
5.9.4 Perkinelmer Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.9.5 Perkinelmer Recent Developments
5.10 Bio-Rad Laboratories
5.10.1 Bio-Rad Laboratories Profile
5.10.2 Bio-Rad Laboratories Main Business
5.10.3 Bio-Rad Laboratories Genotyping Assay Products, Services and Solutions
5.10.4 Bio-Rad Laboratories Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Laboratories Recent Developments
5.11 Eurofins Scientific
5.11.1 Eurofins Scientific Profile
5.11.2 Eurofins Scientific Main Business
5.11.3 Eurofins Scientific Genotyping Assay Products, Services and Solutions
5.11.4 Eurofins Scientific Genotyping Assay Revenue (US$ Million) & (2018-2023)
5.11.5 Eurofins Scientific Recent Developments
6 North America
6.1 North America Genotyping Assay Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genotyping Assay Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genotyping Assay Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genotyping Assay Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genotyping Assay Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genotyping Assay Market Dynamics
11.1 Genotyping Assay Industry Trends
11.2 Genotyping Assay Market Drivers
11.3 Genotyping Assay Market Challenges
11.4 Genotyping Assay Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
